Animals in Research

Currently we do not have an approved animal facility at Argonne (the definition of an animal facility is having a live animal on site longer than 12 hours). Please refer any questions to the Biosafety Officer.

• USDA Animal Health

Bacterial Strains

• Bacteria Database - National Center for Biotechnology Information, U.S. National Library of Medicine
• CDC Diseases Listing

Biosafety Levels and Checklists

• Recognizing the Biosafety Levels - CDC Office of Health and Safety

Bloodborne Pathogens

• OSHA Workplace Precautions against Bloodborne Pathogens
• U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis
  • Appendix A: Practice Recommendations for Health-Care Facilities Implementing the U.S. Public Health Service Guidelines for Management of Occupational Exposures to Bloodborne Pathogens
  • Appendix B: Management of Occupational Blood Exposures
  • Appendix C : Basic and Expanded HIV Postexposure Prophylaxis Regimens
• CDC: Viral Hepatitis
• Needlestick Safety and Prevention Act

CDC-NIH Guidelines

• Biosafety in Microbiological and Biomedical Laboratories

Containment Facilities

• Lawrence Berkeley National Laboratory Biosafety Program: Containment

Disinfection

• Argonne Decontamination and Disinfection Fact Sheet
• Selected EPA-Registered Disinfectants
• CDC References: Disinfection and Sterilization

Human Subjects Issues

Currently Argonne does not have an institutional review board. Any human subjects issues are reviewed by the IRB at University of Chicago

• Research Using Human Subjects/Materials
• Office for Human Research Protections (DHHS-OHRP)

Importation Permits for Etiologic Agents, Cell Lines, and Live Animals

• CDC Etiologic Agent Import Permit Program
• USDA Animal and Plant Health Inspection Service (APHIS) Forms

Infectious Agents

• Category A Infectious Substances
• WHO Infectious Diseases

Organizations

• Centers For Disease Control and Prevention
• DOE Office of Environment, Health, Safety & Security
• NIH Office of Biotechnology Activities
• University of Chicago Institutional Biosafety Committee
• World Health Organization

Prions

• CDC Prion Diseases
• WHO: Bovine spongiform encephalopathy (BSE)

Recombinant DNA Guidelines

• NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules: FAQs

Regulated Medical Waste

Medical waste is:

• Any solid waste generated in the diagnosis, treatment, or immunization of human beings or animals, in research pertaining thereto, or in the production or testing of biologicals, excluding hazardous waste identified or listed under 40 CFR Part 261 or any household waste as defined in 40 CFR Subsection 261.4 (b)(1). (EPA Terms and Acronyms)
• Infectious agents such as human pathological wastes, human blood, and blood products, used or unused sharps (syringes, needles, and blades), certain animal waste, and certain isolation waste 

Safety Manuals

• Biosafety in Microbiological and Biomedical Laboratories

Select Agents

• CDC National Select Agent Registry

Shipping of Specimens/IATA

• Advanced Photon Source Shipping Information
  • Soil Samples
  • Summary of IATA Shipping Information
• CDC Interstate Shipment of Etiologic Agents
• WHO Guidelines for the Safe Transport of Infectious Substances and Diagnostic Specimens
• WHO: Transport of Infectious Substances

Virus-Specific Information

Adenovirus

• CDC: Adenoviruses

Dengue

• CDC: Dengue
• WHO Health Topics: Dengue

HIV

• CDC: HIV/AIDS Fact Sheets
• WHO Health Topics: HIV/AIDS

SARS

• CDC: SARS
• WHO - Summary of the Discussion and Recommendations of the SARS Laboratory Workshop, 22 Oct 2003

Viral Hepatitis

• CDC: Viral Hepatitis

West Nile Virus

• CDC: West Nile Virus